Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.
Researchers identified that Morganella morganii, a gut bacterium, produces an inflammation-triggering molecule when exposed to common pollutants, potentially contributing to depression via immune mechanisms. The discovery suggests new treatment approaches targeting immune system pathways rather than exclusively targeting brain chemistry.
UC Davis researchers developed novel compounds that activate serotonin receptors associated with neuroplasticity and mental health in animal models, without producing hallucinations. The work represents early-stage discovery that may eventually inform treatments for depression, PTSD, and addiction.
Researchers from Nordic and German institutions are developing DNA-based testing using polygenic risk scores to predict antidepressant medication effectiveness for depression and anxiety patients. This pharmacogenomic approach analyzes genetic variations associated with mental health conditions and medication response to potentially reduce treatment trial-and-error.
This study examines molecular and biological changes associated with depression's progression over time. Research of this type contributes to understanding neurobiological mechanisms underlying depression and may inform evidence-based treatment approaches.
Bright light therapy (BLT) is a evidence-based intervention that regulates mood by influencing circadian rhythms through light-sensitive retinal pathways to the suprachiasmatic nucleus. Strong clinical evidence supports BLT for seasonal affective disorder and major depressive disorder, with emerging benefits for bipolar disorder and insomnia, demonstrating excellent tolerability.
